14.05
Quidelortho Corp stock is traded at $14.05, with a volume of 629.06K.
It is up +1.30% in the last 24 hours and up +32.17% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
See More
Previous Close:
$13.87
Open:
$13.86
24h Volume:
629.06K
Relative Volume:
0.23
Market Cap:
$963.48M
Revenue:
$2.66B
Net Income/Loss:
$-1.21B
P/E Ratio:
-0.7884
EPS:
-17.82
Net Cash Flow:
$-159.40M
1W Performance:
+13.22%
1M Performance:
+32.17%
6M Performance:
-19.67%
1Y Performance:
-48.55%
Quidelortho Corp Stock (QDEL) Company Profile
Name
Quidelortho Corp
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
QDEL
Quidelortho Corp
|
14.05 | 963.48M | 2.66B | -1.21B | -159.40M | -17.82 |
|
ABT
Abbott Laboratories
|
104.52 | 180.86B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
95.31 | 121.91B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
291.62 | 111.86B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.80 | 63.47B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.60 | 49.92B | 6.30B | 1.07B | 1.09B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-26 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-25 | Downgrade | Citigroup | Buy → Neutral |
| May-08-25 | Upgrade | Jefferies | Hold → Buy |
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Sep-19-24 | Resumed | UBS | Neutral |
| Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-04-24 | Downgrade | UBS | Neutral → Sell |
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corp Stock (QDEL) Latest News
Reasons to Add QuidelOrtho Stock to Your Portfolio for Now - Zacks Investment Research
Quidel Corporation (NASDAQ: QDEL) Share Price, QDEL Stock News, QDEL Share Price & Updates - kalkine.ca
Quidel Corporation (QDEL) stock price, news, quote and history - Yahoo Finance UK
QuidelOrtho Corporation (QDEL) Stock Price, News, Quote & History - Yahoo! Finance Canada
QuidelOrtho Updates Credit Agreement, Revises Financial Covenants Through 2029 - Kalkine Media
A $1.15B loan is covered by QuidelOrtho (QDEL)'s revised borrowing terms, with limits set through 2029. - Stock Titan
SRXH Stock Climbed 15% Today — What’s Driving The Rally? - Stocktwits
QuidelOrtho stock slips after insider share withholding while fundamentals stay in focus - AD HOC NEWS
Is QuidelOrtho Corp (QDEL) a Bargain After 3.1% Drop? GF Value S - GuruFocus
QDEL stock gains as QuidelOrtho beats estimates and trades near target - ad-hoc-news.de
QuidelOrtho (QDEL) Drops 3.79% to $14.74: Diagnostics Stock Presses Against SupportFibonacci Fan - siam.in
Respiratory test results can arrive in as little as six minutes - Stock Titan
QuidelOrtho (NASDAQ:QDEL) Stock Price Down 3.4%Should You Sell? - MarketBeat
Tejara Capital Ltd Takes $2.27 Million Position in QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Shares Up 6.9%Here's What Happened - MarketBeat
QuidelOrtho Corporation’s Margin Recovery Meets China, Respiratory & Cash Flow Headwinds ! - Smartkarma
QuidelOrtho EVP Bryan Hanson Reports RSU Vesting and Tax-Related Share Withholding - Kalkine Media
QuidelOrtho (QDEL) Earnings Check: Reported EPS Tops Expectations for the Current Session; Market Follow-Through: Shares Close 8.44% LowerLow Estimate Range - Vinanet
Rice Hall James & Associates LLC Invests $18.63 Million in QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho Corp (QDEL) exec’s RSUs vest as shares withheld for tax - Stock Titan
QuidelOrtho (QDEL) Is Up 6.0% After Cutting 2026 Revenue Outlook Amid Narrowing Losses – What's Changed - Yahoo Finance
Healthcare Equipment and Supplies Stocks Q2 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers - StockStory
Healthcare Equipment and Supplies Stocks Q2 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers - Barchart.com
QuidelOrtho Corp (QDEL) Stock Down 5.2% -- Now Undervalued? GF S - GuruFocus
QuidelOrtho (NASDAQ:QDEL) Stock Rating Lowered by Zacks Research - MarketBeat
QuidelOrtho (QDEL) Is Down 7.5% After Cutting 2026 Revenue Outlook Amid Softer COVID Testing Demand - simplywall.st
QuidelOrtho (QDEL) Is Down 7.5% After Cutting 2026 Revenue Outlook Amid Softer COVID Testing Demand - simplywall.st
QuidelOrtho (QDEL) Q2 2026 Earnings Call Transcript - AOL.com
Invesco Ltd. (QDEL holder) reports 5.1% beneficial stake in QuidelOrtho Corp - Stock Titan
QuidelOrtho (QDEL) Stock Sees Fair Value Cut As Analysts Rework Growth Expectations - Yahoo Finance
QuidelOrtho Corporation (QDEL) Stock Forecasts - Yahoo Finance
QuidelOrtho Corp (QDEL) Stock Up 6.0% and Still Undervalued -- G - GuruFocus
Neuberger Berman Group LLC Trims QuidelOrtho Corp (QDEL) Stake -- Shares Trade 59% Below GF Value - GuruFocus
Why QuidelOrtho (QDEL) Stock Is Nosediving - Yahoo Finance
QuidelOrtho partially recovers from earnings slide, rising 12% (QDEL:NASDAQ) - Seeking Alpha
QuidelOrtho (NASDAQ:QDEL) Shares Up 8.5%Should You Buy? - MarketBeat
QuidelOrtho Corporation (QDEL) Stock Positioned for Reweighting Towards Peers Amid Deleveraging - Yahoo Finance
QuidelOrtho Corporation revenue up 3% to USD 631M in Q2 2026 - Medical Buyer
QuidelOrtho Corp (QL1A.DU) options chain - Yahoo Finance Australia
QuidelOrtho (QDEL) Stock Sinks As Cash Burn And Debt Eclipse Progress - Sahm
Nasdaq Gains Over 300 Points; US Employers Cut 23,000 Jobs In July - Benzinga
QuidelOrtho Corporation 2026 Q2ResultsEarnings Call Presentation (NASDAQ:QDEL) 2026-08-07 - Seeking Alpha
Why QuidelOrtho (QDEL) Stock Is Nosediving - StockStory
Why QuidelOrtho (QDEL) Stock Is Nosediving - TradingView
Why QuidelOrtho (QDEL) Stock Is Nosediving - FinancialContent
QuidelOrtho (NASDAQ:QDEL) Shares Gap DownTime to Sell? - MarketBeat
QuidelOrtho Corp (QDEL) Stock News Today - TradingKey
QuidelOrtho stock drops after Q2 results (QDEL:NASDAQ) - Seeking Alpha
QuidelOrtho Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
QuidelOrtho 2Q Rev $630.9M >QDEL - Moomoo
Quidelortho Corp Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quidelortho Corp Stock (QDEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hanson Bryan Michael | EVP Global Port. Mgmt & Mkting |
Aug 15 '26 |
Option Exercise |
0.00 |
446 |
0 |
8,217 |
| Hanson Bryan Michael | EVP Global Port. Mgmt & Mkting |
Jul 01 '26 |
Option Exercise |
0.00 |
5,797 |
0 |
9,867 |
| Blaser Brian J. | President and CEO |
Feb 13 '26 |
Buy |
23.59 |
10,540 |
248,661 |
40,073 |
| Busky Joseph M. | Chief Financial Officer |
Feb 13 '26 |
Buy |
23.66 |
3,370 |
79,742 |
10,290 |
| Strobeck Matthew | Director |
Feb 13 '26 |
Buy |
23.96 |
10,000 |
239,586 |
27,775 |
| RHOADS ANN D | Director |
Dec 10 '25 |
Buy |
28.27 |
750 |
21,206 |
15,021 |
| Wilkins Joseph D Jr. | Director |
Nov 26 '25 |
Buy |
27.95 |
370 |
10,343 |
11,876 |
| KENNETH WIDDER | Director |
Nov 25 '25 |
Proposed Sale |
27.81 |
4,026 |
111,965 |
0 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Sale |
27.81 |
4,026 |
111,965 |
37,061 |
| WIDDER KENNETH J | Director |
Nov 25 '25 |
Option Exercise |
15.74 |
7,021 |
110,511 |
41,087 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):